|
|
||||||||
The Journal of Immunology, Vol 142, Issue 6 2046-2051, Copyright © 1989 by American Association of Immunologists
ARTICLES |
LJ Picker, J De los Toyos, MJ Telen, BF Haynes and EC Butcher
Department of Pathology, Stanford University School of Medicine, CA 94305.
An 85- to 95 kDa class of lymphocyte surface molecules, defined in man by antibodies of the Hermes series, is involved in lymphocyte binding to high endothelial venules and is likely of central importance in the process of lymphocyte homing. In this report, we have examined the relationship between these Hermes-defined "homing-receptors" and two other 80 to 95 kDa lymphocyte surface molecules that have been extensively studied--CD44 [In(Lu)-related p80] defined by mAb A1G3 and A3D8, and Pgp-1 defined by antibody IM7. Our findings indicate that, in man, similar or identical glycoprotein(s) are recognized by these independently and diversely obtained antibodies. All antibodies showed identical immunohistologic patterns of reactivity on a variety of lymphoid and nonlymphoid human tissues, and demonstrated similar bands on Western blots of both crude tonsil lymphocyte lysates and highly purified Hermes-1 Ag preparations. Similarly, purified CD44/p80 Ag from RBC and human serum bound Hermes-1. Preclearing of tonsil lysates with the Hermes-1 antibody removed antigenic activity for all antibodies. Cross-blocking experiments demonstrated that A3D8, IM7 (anti-Pgp-1), and Hermes-2 antibodies recognize overlapping epitopes. Finally, expression of the epitopes defined by the Hermes-1, Hermes-3, H2-7, and H3-61 antibodies on RBC was shown to be regulated by the In(Lu) gene. These findings unify several different lines of investigation, and suggest the possibility that the CD44/Pgp-1/Hermes class of molecules may serve as cell-cell or cell-substrate adhesion/recognition elements for both hematolymphoid and non-hematolymphoid cell types.
This article has been cited by other articles:
![]() |
M. Zoller, P. Gupta, R. Marhaba, M. Vitacolonna, and P. Freyschmidt-Paul Anti-CD44-mediated blockade of leukocyte migration in skin-associated immune diseases J. Leukoc. Biol., July 1, 2007; 82(1): 57 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mu, S. Cambier, L. Fjellbirkeland, J. L. Baron, J. S. Munger, H. Kawakatsu, D. Sheppard, V. C. Broaddus, and S. L. Nishimura The integrin {alpha}v{beta}8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-{beta}1 J. Cell Biol., April 29, 2002; 157(3): 493 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. W. Van Hal, G. A. M. S. Van Dongen, C. B. M. Ten Brink, K.-H. Heider, I. Rech-Weichselbraun, G. B. Snow, and R. H. Brakenhoff Evaluation of Soluble CD44v6 as a Potential Serum Marker for Head and Neck Squamous Cell Carcinoma Clin. Cancer Res., November 1, 1999; 5(11): 3534 - 3541. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ingvarsson, K. Dahlenborg, R. Carlsson, and C. A. K. Borrebaeck Co-ligation of CD44 on naive human tonsillar B cells induces progression towards a germinal center phenotype Int. Immunol., May 1, 1999; 11(5): 739 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Banerji, J. Ni, S.-X. Wang, S. Clasper, J. Su, R. Tammi, M. Jones, and D. G. Jackson LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan J. Cell Biol., February 22, 1999; 144(4): 789 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Faassen, D. Mooradian, R. Tranquillo, R. Dickinson, P. Letourneau, T. Oegema, and J. McCarthy Cell surface CD44-related chondroitin sulfate proteoglycan is required for transforming growth factor-beta-stimulated mouse melanoma cell motility and invasive behavior on type I collagen J. Cell Sci., January 6, 1993; 105(2): 501 - 511. [Abstract] [PDF] |
||||
![]() |
C. Underhill CD44: the hyaluronan receptor J. Cell Sci., October 1, 1992; 103(2): 293 - 298. [PDF] |
||||
![]() |
A. Freedman, J. Munro, G. Rice, M. Bevilacqua, C Morimoto, B. McIntyre, K Rhynhart, J. Pober, and L. Nadler Adhesion of human B cells to germinal centers in vitro involves VLA-4 and INCAM-110 Science, August 31, 1990; 249(4972): 1030 - 1033. [Abstract] [PDF] |
||||
![]() |
S Kamel-Reid, M Letarte, C Sirard, M Doedens, T Grunberger, G Fulop, M. Freedman, R. Phillips, and J. Dick A model of human acute lymphoblastic leukemia in immune-deficient SCID mice Science, December 22, 1989; 246(4937): 1597 - 1600. [Abstract] [PDF] |
||||
![]() |
J. Strominger Developmental biology of T cell receptors Science, May 26, 1989; 244(4907): 943 - 950. [Abstract] [PDF] |
||||
![]() |
D. Mu, S. Cambier, L. Fjellbirkeland, J. L. Baron, J. S. Munger, H. Kawakatsu, D. Sheppard, V. C. Broaddus, and S. L. Nishimura The integrin {alpha}v{beta}8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-{beta}1 J. Cell Biol., April 29, 2002; 157(3): 493 - 507. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |